DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Manufacturing and Efficacy of Axi-Cel in R/R LBCL Jun 19, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma High ORR & Safety of Epcoritamab + Pola-R-CHP in 1L DLBCL Jun 17, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Glofit-GemOx Improves Survival in R/R DLBCL Jun 17, 2024
CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Epcoritamab Shows Promise in RT: EPCORE CLL-1 Trial Jun 13, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ARG Signature Prognosis & Treatment Promise in DLBCL May 30, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma HBsAg Positive Linked to Worse DLBCL Prognosis May 15, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Managing CAR-T Failure: Chidamide & PD-1 Blockade in LBCL May 14, 2024